There is 1 paper on SV2A density in aging research: 1 observational study in people.
1 paper studies it2 more mention it5 findings
See all 3 papers on SV2A density
“observed disease- and region-specific reductions, with the most severe in FTLD-GRN (up to 59.5%) and EOAD.”
- Humans1
Associations
5SYP density
upin humans1
1 study
SYP density
upin humans1
SV2A density is associated with SYP density in humans (strong positive correlation).
Humansbrain
Progressive supranuclear palsy
downin humans1
1 study
Progressive supranuclear palsy
downin humans1
Progressive supranuclear palsy is associated with SV2A density in humans (compared with healthy controls).
Humanscompared with healthy controlshippocampal formation
Late-onset Alzheimer's disease
downin humans1
1 study
Late-onset Alzheimer's disease
downin humans1
Late-onset Alzheimer's disease is associated with SV2A density in humans (compared with healthy controls) (over 30% declines).
Humanscompared with healthy controlsinferior frontal gyrus and hippocampal CA1
Early-onset Alzheimer's disease
downin humans1−49% reduction
1 study
Early-onset Alzheimer's disease
downin humans1−49% reduction
Early-onset Alzheimer's disease is associated with SV2A density in humans (compared with healthy controls) (49% reduction).
Humanscompared with healthy controlsmiddle frontal gyrus
Frontotemporal lobar degeneration
downin humans1−60% reduction
1 study
Frontotemporal lobar degeneration
downin humans1−60% reduction
Frontotemporal lobar degeneration is associated with SV2A density in humans (FTLD-GRN compared with healthy controls) (up to 59.5% reduction).
HumansFTLD-GRN compared with healthy controlscerebral cortex